Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial.
Am J Gastroenterol
; 118(7): 1184-1195, 2023 07 01.
Article
in En
| MEDLINE
| ID: mdl-36940437
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Helicobacter pylori
/
Helicobacter Infections
Type of study:
Clinical_trials
Limits:
Adult
/
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Am J Gastroenterol
Year:
2023
Type:
Article
Affiliation country:
Taiwan